Navigation Links
The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
Date:11/6/2007

Over 300 implants reported in the intended patient population for company's

minimally invasive knee implant.

MINNEAPOLIS, Nov. 6 /PRNewswire/-- Advanced Bio-Surfaces, Inc., (ABS) an orthopedic implant developer and manufacturer, announced today the OrthoGlide Medial Knee Implant has been implanted in more than 300 patients in the USA. The OrthoGlide implant is a minimally invasive device intended to relieve pain caused by moderate osteoarthritis of the knee.

"The interest from surgeons and patients for a minimally invasive alternative to the current knee replacement options on the market continues to expand," said Dr. Jeff Felt, Chairman of Advanced Bio-Surfaces. "We have increased the number of training sites in the United States in an effort to accommodate the number of interested surgeons. As the surgeon community learns more about the product and its minimal surgical approach, they understand the need for the OrthoGlide implant as a viable option for some patients. The growth is inspired by surgeons who want to be trained on a procedure that can be positioned as an alternative to total knee replacement."

In addition to training and supporting the orthopedic surgeon community interested in the OrthoGlide implant, ABS is also involved in a clinical study. This week, during the American College of Rheumatology's annual meeting in Boston, MA, William Arnold, M.D. will present data from the study that supports the OrthoGlide's clinical effectiveness. The presentation will be held in Room 153 of the Boston Convention and Exhibit Center at 5:30 p.m. on Saturday, November 10th.

About Advanced Bio-Surfaces, Inc.

ABS is a privately held company dedicated to the development of innovative joint restoration products. The company's first product, the OrthoGlide Medial Knee Implant, is intended for the treatment of patients with moderate osteoarthritis of the medial compartment. The company received 510(k) clearance to
'/>"/>

SOURCE Advanced Bio-Surfaces, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
2. Adult Smoking Rate Continues Downward Trend
3. Gilbert Hospital Continues Cutting Edge Treatments
4. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
7. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
8. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
9. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
10. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
11. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that it will release ... 10, 2015 after the close of the U.S. financial ... webcast on Monday, August 10, 2015 at 4:30 p.m. ... and corporate developments. For both "listen-only" participants ...
(Date:7/29/2015)... Calif. , July 29, 2015  Depomed, ... today announced that its Board of Directors, after ... independent financial and legal advisors, has unanimously rejected ... proposal from Horizon Pharma plc (NASDAQ: HZNP ... shares of Depomed in an all-stock transaction (the ...
(Date:7/29/2015)... July 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: ... of up to $21.5 million through two financing agreements. ... HTGC ) ("Hercules"), for a term loan of up ... Discover Growth Fund ("Discover"), for the sale to Discover ... ("Preferred Stock") for up to $12 million in gross ...
Breaking Medicine Technology:Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7
... with Scripps Florida and Scripps Research in La ... ... FRANCISCO, Calif., and LA JOLLA, Calif., May 14 /PRNewswire-,FirstCall/ -- Poniard ... and The Scripps Research,Institute, a non-profit biomedical research organization, today announced,that ...
... DOYLESTOWN, Pa., May 14 The Quigley,Corporation (Nasdaq: ... study,conducted by its wholly owned subsidiary, Quigley Pharma ... anti-viral activity of its compound,QR448(a). The compound was ... Bronchitis Virus (IBV). The data from the study ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:7/30/2015)... ... July 30, 2015 , ... PeopleKeys, a company with over 30 ... Train the Trainer” webinar. The webinar, the newest installment in their popular DISC for ... The Managing Stress: Train the Trainer webinar is intended for people interested in training ...
(Date:7/29/2015)... ... 30, 2015 , ... Drs. Hamstead are very excited to announce the expansion ... the offerings in the clinic; massage therapy works very well alongside chiropractic care to ... has joined AlignLife of Simpsonville to work alongside the doctors. Many people can benefit ...
(Date:7/29/2015)... ... ... to an article published July 23 by the Daily Mail, a new online ... needs to do in terms of physical activity and caloric intake to lose weight. Based ... the number of calories a person needs to consume to maintain or lose weight at ...
(Date:7/29/2015)... California (PRWEB) , ... July 29, 2015 , ... Conventional ... sell, and trade goods and services may be able to unlock mysteries about the ... Claremont Graduate University , Boston University, and Columbia University. , The findings, published July ...
(Date:7/29/2015)... Richey, FL (PRWEB) , ... July 29, 2015 ... ... nation have become increasingly aware of the impact drinking and substance abuse is ... increased illness. Financial loss is tagged in the billions per year. [1] Will ...
Breaking Medicine News(10 mins):Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:AlignLife of Simpsonville Hires Massage Therapist 2Health News:New NIH Body Weight Planner Illustrates the Need for Reduced Caloric Intake When Trying to Lose Weight, Says Beverly Hills Physicians 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3
... Outlines Ways to Lower Costs and Expand Health Coverage for More ... HMS , the nation,s leader in cost management ... to Congress for reducing healthcare costs while expanding coverage under ... (CHIP), and other government programs. , , "In ...
... of GERD complications in any United States general ... thought that such complications occur less frequently in ... in Jacksonville, FL investigated the prevalence of reflux ... of esophagitis severity and its complications were equivalent ...
... Winners Demonstrates Strong Employer Commitment , to Workplace Health & ... The National Business Group on Health (NBGH) is pleased ... of the U.S. economy -- have been recognized as "2009 ... their exceptional commitment to a healthy workplace and for helping ...
... LAKE CITY, June 24 Dynatronics Corporation (Nasdaq: ... new V-Force Vibration Therapy units to customers. These new ... training to increase strength, improve balance and enhance flexibility. ... program to compensate for bone and muscle loss resulting ...
... attendees hands-on experience , , RESEARCH TRIANGLE PARK, N.C., ... manufacturer of bone tissue regeneration and dental implant products, has ... in Chicago Friday, July 24th from 8:00 am to 4:00 ... information on bone grafting materials and methods, and hands-on experience ...
... aging, but good habits can help you cope, experts say ... off the mental decline associated with old age, engage in ... your social life. , Those are the findings of ... aging and the brain. , The review, which spanned three ...
Cached Medicine News:Health News:HMS Urges Healthcare Reform Measures to Manage Costs, Target Resources, Fight Fraud 2Health News:What is different in reflux esophagitis between African-Americans and non-Hispanic whites? 2Health News:National Business Group on Health Recognizes 63 Large Employers as '2009 Best Employers for Healthy Lifestyles' Award Winners 2Health News:National Business Group on Health Recognizes 63 Large Employers as '2009 Best Employers for Healthy Lifestyles' Award Winners 3Health News:Dynatronics Begins Shipping New V-Force Vibration Therapy Units 2Health News:Dynatronics Begins Shipping New V-Force Vibration Therapy Units 3Health News:RIEMSER Announces Upcoming Chicago Bone Grafting Workshop 2Health News:Stay Upbeat, Active to Keep the Mind Young 2Health News:Stay Upbeat, Active to Keep the Mind Young 3
... The new Primus PDQ Plus for the determination ... and accurate results. The PDQ Plus is a ... on-line barcode reading for the ultimate in safety ... affinity which is well known to be interference-free ...
Micromat II Hemoglobin A1c instrument is an easy-to-use, accurate and precise instrument with an requirement of only 10 L of capillary or venous sample....
... Cascade M-4 is a manual hemostasis ... routine clotting assays - PTs, aPTTs, ... for easy, inexpensive, low-volume testing, this ... big on features, offering time and ...
... a fully automated, benchtop coagulation workstation ... immunological assays in true random access ... sample management offers high throughput and ... the need to interrupt current testing. ...
Medicine Products: